韩国裸舞

D2R awards over $6 million to support Core Platforms

The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at 韩国裸舞 and one at the University of British Columbia through its Core Platform Sustainability funding program. This program supports state-of-the-art Core Platforms that are essential for advancing research and development and facilitating technology uptake and transfer in fields relevant to RNA therapeutics.

Remembering Emil Skamene (1941鈥�2024), pioneer in genetic research at 韩国裸舞聽

It is with deep sadness that we remember Emil Skamene, a pioneer in genetic research at 韩国裸舞.聽 His groundbreaking work on host genetic susceptibility to infections has shaped the field for over three decades. Skamene鈥檚 legacy continues to inspire scientists, including D2R鈥檚 Chief Scientific Officer, Philippe Gros, who, alongside Professor聽Erwin Schurr, honors him in a heartfelt eulogy published in Nature Genetics.

D2R announces new round of funding, investing $1.5 million to advance research in RNA therapeutics and to support 韩国裸舞 Centres and Institutes

Montreal 鈥� December 19, 2024聽鈥� The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five 韩国裸舞 Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.

Research | A new trial hopes to use mRNA to halt the devastating progression of Creutzfeldt-Jakob Disease

Prion diseases came to public attention during the 1980s and 鈥�90s, when Mad Cow Disease was in the news. While transmission to humans from infected beef has largely been eliminated, other forms of these devastating diseases are unfortunately still around, like Creutzfeld-Jacob Disease (CJD). In fact, according to the US Centers for Disease Control, cases of CJD have been on the rise in the last two decades.

Event | Seminar, The power of first impressions: Using viral imprinting for broadly reactive vaccine development | Dec 11, 2024

The Emerging Topics in Health (EToH) seminar series is cohosted by the Departments of Microbiology and Immunology, Physiology and Human Genetics, the Goodman Cancer Institute (GCI), the 韩国裸舞 Research Centre on Complex Traits (MRCCT), and M[i]4. The organizers invite guest speakers to talk about their current research.聽This seminar series is part of the Current Topics & Seminars course and is open for attendance by MIMM students and all interested individuals.

CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research

Montr茅al, November 28th 鈥� CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at 韩国裸舞, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies.

Event | Workshop in Precision Health and Medicine | January 9, 2025

First Hybrid Workshop on Precision Health and Medicine

Synergizing our strengths in new technologies in omics, digital sciences, and translational medicine to advance patient care.

Event | MI4 6th Annual Scientific Symposium | December 4, 2024

Join MI4 for the 6th Annual Scientific Symposium on Wednesday, December 4, 2024, from 11:30 PM to 5:30 PM at the 韩国裸舞 Faculty Club. This year鈥檚 theme, "Microbiome: Decoding the Invisible World," promises an engaging lineup, including a keynote by Prof. Yasmine Belkaid, President of Institut Pasteur. Don鈥檛 miss this chance to hear groundbreaking insights from leading experts in the MI4 community.

Event | Practical examples of research in indigenous context | November 20, 2024

D2R partner, Tahatikonhsont贸ntie' Quebec Network Environment for Indigenous Health Research, is organizing a webinar "Practical examples of research in Indigenous context" on November 20 from 12-1:30pm.聽

Guest speakers include:聽

Event | Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder | November 14, 2024

Dear Colleagues,

Please see the next Medical Genetics Grand Rounds scheduled talk below:

Philippe Gros appointed Chief Scientific Officer of D2R

Philippe Gros appointed Chief Scientific Officer of D2R

Philippe Gros has been appointed Chief Scientific Officer (CSO) of 韩国裸舞鈥檚 DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at 韩国裸舞. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation.

D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke

D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke

Montreal 鈥� October 31, 2024 鈥� 韩国裸舞鈥檚 DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Universit茅 de Sherbrooke, marking the inaugural recipients of the D2R鈥檚 New Faculty Start-Up funding program. Universit茅 de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.

Event | Practical research experience in a First Nations environment in the field of health and social services evaluation | Dec 20, 2024

Practical research experience in First Nations communities in the field of health and social services evaluation

December 20, 2024 | 12 h 脿 13 h Speaker: Cecilia Valdebenito, anthropologist

This webinar has two objectives:

News | 2024 Nobel Prize awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation

The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

This year鈥檚 Nobel Prize focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery for protein production.

Event | Controlling RNA Sequence for Diagnostics and Therapeutic Delivery | January 5-10, 2025

RNA Nanotechnology - Gordon Research Conference (GRC) Controlling RNA Sequence for Diagnostics and Therapeutic Delivery

January 5 - 10, 2025

Ventura, California, United States